1. 2017/745 Of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC;Regulation (EU;OJ L,2017
2. No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC;Regulation (EU;OJ L,2014
3. Code of Federal Regulations (CFR). Title 21 Part 312 - Investigational New Drug Application. U.S. Food and Drug Administration. [cited 2023 May 7]. Available at https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&SID=4e36990a5a57b3d4b4f96bfe6170b59e&ty=HTML&h=L&mc=true&=PART&n=pt21.5.312.
4. Code of Federal Regulations (CFR). Title 21 Part 812 - Investigational Device Exemptions. U.S. Food and Drug Administration. [cited 2023 May 7]. Available at https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&SID=4e36990a5a57b3d4b4f96bfe6170b59e&ty=HTML&h=L&mc=true&=PART&n=pt21.8.812.
5. Reform of Drug Regulation — Beyond an Independent Drug-Safety Board